NO995389L - COX-2 selective carprofen for the treatment of pain and inflammation in dogs - Google Patents

COX-2 selective carprofen for the treatment of pain and inflammation in dogs

Info

Publication number
NO995389L
NO995389L NO995389A NO995389A NO995389L NO 995389 L NO995389 L NO 995389L NO 995389 A NO995389 A NO 995389A NO 995389 A NO995389 A NO 995389A NO 995389 L NO995389 L NO 995389L
Authority
NO
Norway
Prior art keywords
carprofen
cox
dogs
inflammation
pain
Prior art date
Application number
NO995389A
Other languages
Norwegian (no)
Other versions
NO995389D0 (en
Inventor
Kristin Marie Lundby
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO995389D0 publication Critical patent/NO995389D0/en
Publication of NO995389L publication Critical patent/NO995389L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO995389A 1997-05-05 1999-11-04 COX-2 selective carprofen for the treatment of pain and inflammation in dogs NO995389L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (2)

Publication Number Publication Date
NO995389D0 NO995389D0 (en) 1999-11-04
NO995389L true NO995389L (en) 2000-01-04

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995389A NO995389L (en) 1997-05-05 1999-11-04 COX-2 selective carprofen for the treatment of pain and inflammation in dogs

Country Status (32)

Country Link
EP (1) EP0988034A1 (en)
JP (1) JP2000513020A (en)
KR (2) KR20040004406A (en)
CN (1) CN1255059A (en)
AP (1) AP9801234A0 (en)
AR (2) AR011726A1 (en)
AU (1) AU6932198A (en)
BG (1) BG103852A (en)
BR (1) BR9808720A (en)
CA (1) CA2288759A1 (en)
DZ (1) DZ2479A1 (en)
EA (1) EA003696B1 (en)
GT (1) GT199800063A (en)
HR (1) HRP980244A2 (en)
HU (1) HUP0001286A3 (en)
ID (1) ID21311A (en)
IL (1) IL132570A0 (en)
IS (1) IS5220A (en)
MA (1) MA26491A1 (en)
NO (1) NO995389L (en)
NZ (1) NZ500183A (en)
OA (1) OA11213A (en)
PA (1) PA8450601A1 (en)
PE (1) PE72599A1 (en)
PL (1) PL337003A1 (en)
SK (1) SK148199A3 (en)
TN (1) TNSN98059A1 (en)
TW (1) TW590773B (en)
UY (1) UY24989A1 (en)
WO (1) WO1998050033A1 (en)
YU (1) YU55899A (en)
ZA (1) ZA983722B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
CA2347365A1 (en) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
EP1637137A3 (en) * 1999-03-10 2006-07-05 G.D. Searle LLC Method and composition for administering a cyclooxygenase-2 inhibitor to animals
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2004521856A (en) * 2000-05-15 2004-07-22 メルク フロスト カナダ アンド カンパニー Combination therapy using a COX-2 selective inhibitor and a thromboxane inhibitor and compositions therefor
BR0111767A (en) 2000-06-13 2003-07-08 Wyeth Corp Analgesic and anti-inflammatory compositions containing cox-2 inhibitors, their use and method for enhancing an analgesic compound
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
AU2001284753B2 (en) 2000-08-07 2006-10-26 Vanderbilt University Detection of COX-2 activity and anandamide metabolites
WO2003007875A2 (en) * 2001-07-16 2003-01-30 Hoegestaett Edward Compounds with analgesic, antipyretic and/or anti-inflammatory activity
JP4354984B2 (en) 2003-05-07 2009-10-28 オステオロジックス エイ/エス Treatment of cartilage / bone symptoms with water-soluble strontium salts
JP2007500691A (en) * 2003-07-31 2007-01-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Dispersible formulation of anti-inflammatory agent
CA2608010A1 (en) * 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
PT2079456E (en) 2007-04-04 2013-03-13 Sigmoid Pharma Ltd Pharmaceutical cyclosporin compositions
WO2008132707A1 (en) 2007-04-26 2008-11-06 Sigmoid Pharma Limited Manufacture of multiple minicapsules
BRPI1012196B1 (en) 2009-05-18 2021-11-30 Sublimity Therapeutics Limited COMPOSITION INCLUDING OIL DROPS
GB2485327A (en) 2009-08-12 2012-05-09 Sigmoid Pharma Ltd Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CN105939713A (en) * 2014-03-06 2016-09-14 阿莱塔纳治疗学股份有限公司 Compositions of grapiprant and methods for using same
CN107106644B (en) 2014-11-07 2022-04-15 卓越治疗有限公司 Cyclosporin-containing compositions
EP3242557A4 (en) * 2015-01-09 2018-09-05 Jaguar Health, Inc. Methods of treating diarrhea in companion animals
EP4125874A4 (en) * 2020-03-25 2024-05-01 Stanford Res Inst Int Lipoxygenase inhibitors
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (en) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 Pharmaceutical composition for preventing or treating keloid or hypertrophic scar comprising Benzbromarone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
GT199800063A (en) 1999-10-26
YU55899A (en) 2003-08-29
EA003696B1 (en) 2003-08-28
EA199900895A1 (en) 2000-06-26
EP0988034A1 (en) 2000-03-29
NZ500183A (en) 2002-04-26
CN1255059A (en) 2000-05-31
WO1998050033A1 (en) 1998-11-12
JP2000513020A (en) 2000-10-03
TW590773B (en) 2004-06-11
SK148199A3 (en) 2001-09-11
AR011726A1 (en) 2000-08-30
TNSN98059A1 (en) 2005-03-15
PE72599A1 (en) 1999-08-12
IS5220A (en) 1999-10-19
ZA983722B (en) 1999-11-04
AP9801234A0 (en) 1999-11-04
KR20010012300A (en) 2001-02-15
PA8450601A1 (en) 2000-05-24
NO995389D0 (en) 1999-11-04
MA26491A1 (en) 2004-12-20
UY24989A1 (en) 2001-10-25
BG103852A (en) 2000-06-30
HRP980244A2 (en) 1999-02-28
IL132570A0 (en) 2001-03-19
BR9808720A (en) 2000-07-11
OA11213A (en) 2003-07-14
HUP0001286A3 (en) 2000-12-28
AU6932198A (en) 1998-11-27
PL337003A1 (en) 2000-07-31
CA2288759A1 (en) 1998-11-12
AR039628A2 (en) 2005-03-02
KR20040004406A (en) 2004-01-13
ID21311A (en) 1999-05-20
HUP0001286A2 (en) 2000-11-28
DZ2479A1 (en) 2003-02-01

Similar Documents

Publication Publication Date Title
NO995389L (en) COX-2 selective carprofen for the treatment of pain and inflammation in dogs
NO20005190L (en) Therapeutic angiogenic factors and methods for their use
NO20014560D0 (en) Quinasolines and their therapeutic use
DE69825447D1 (en) DERMATOLOGICAL TREATMENT DEVICE
IS5405A (en) Prostaglandin agonists and their use in the treatment of bone disorders
ID18741A (en) Nicotinic Substance in Therapy
DE69630947D1 (en) PAIN TREATMENT AGENTS
NO20022656L (en) Caspase Inhibitors and Their Use
EE05073B1 (en) Retigabine for use in the treatment of neuropathic pain
DE69805438T2 (en) MIXING AND CHARGING OPENING FOR MEDICAL TREATMENT
NO983576L (en) Well treatment fluids and methods
NO20005179D0 (en) Drug treatment
DE69701250D1 (en) Animal treatment device
ID24060A (en) IMPROVED ANIMAL SKIN TREATMENT
NO20012738D0 (en) Therapeutic products and their use
IT1318619B1 (en) PROCEDURE AND ELECTROCHEMICAL TREATMENT DEVICE.
PT1178981E (en) SUBSTITUTED 3-PYRIDYL-4-ARYLIPYROLS AND THERAPEUTIC AND PROFILACTIC METHODS
DK0915655T3 (en) Method and composition for the treatment of parasites in animal environments
AU5388299A (en) Antibodies for use in targeted and temporary treatment of humans and animals
DE69932577D1 (en) Bar treatment device and bar charger
ID30458A (en) OSANETAN IN TREATMENT OF SOUL DISORDERS
IS6428A (en) Method and mix to treat pain
NO992561D0 (en) Slurry treatment system and slurry treatment method
DE29801793U1 (en) Therapy and treatment device
IS6427A (en) Compound and method of treating pain

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application